According to Dynavax Technologies 's latest financial reports the company's total liabilities are $0.37 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.37 B | -7.36% |
2022-12-31 | $0.40 B | -50.44% |
2021-12-31 | $0.81 B | 177.3% |
2020-12-31 | $0.29 B | 8.79% |
2019-12-31 | $0.27 B | 83.18% |
2018-12-31 | $0.14 B | 668.45% |
2017-12-31 | $19.23 M | -6.07% |
2016-12-31 | $20.47 M | -30.71% |
2015-12-31 | $29.55 M | -21.83% |
2014-12-31 | $37.8 M | 106.29% |
2013-12-31 | $18.32 M | -26.47% |
2012-12-31 | $24.92 M | -27.16% |
2011-12-31 | $34.22 M | 6.48% |
2010-12-31 | $32.13 M | -27.11% |
2009-12-31 | $44.09 M | -40.79% |
2008-12-31 | $74.46 M | -8.42% |
2007-12-31 | $81.31 M | 241.41% |
2006-12-31 | $23.81 M | 315.67% |
2005-12-31 | $5.73 M | -58.39% |
2004-12-31 | $13.77 M | -84.49% |
2003-12-31 | $88.78 M | 1.06% |
2002-12-31 | $87.84 M | 77.35% |
2001-12-31 | $49.53 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 36,487.79% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 24,144.32% | ๐บ๐ธ USA |
Biogen BIIB | $12.04 B | 3,111.90% | ๐บ๐ธ USA |
Gilead Sciences GILD | $39.37 B | 10,399.59% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 18,309.49% | ๐บ๐ธ USA |
AstraZeneca AZN | $61.95 B | 16,419.74% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $58.82 B | 15,585.74% | ๐ฌ๐ง UK |
Agenus
AGEN | $0.46 B | 23.27% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $35.35 B | 9,326.86% | ๐ฎ๐ฑ Israel |